InternationalUSRemember you can easily switch between MIP US and MIP International at any time

In-house roundup: EPO Strategic Plan reactions; Amazon enforcement system caution; considered injunctions wanted; CAR-T patenting conundrums



Patrick Wingrove, London


Managing IP rounds up the latest news and analysis from patent-focused businesses

Drugs

European in-house counsel express mixed feelings on EPO four-year plan 

Lawyers at Gedeon Richter, F-Star and Siemens say they are happy to see a focus on employee satisfaction in the 2023 Strategic Plan, but would also like to see a higher emphasis on quality. Read More... 

Amazon patent enforcement system is "useful for simple matters" 

With Amazon launching a pilot patent evaluation programme for take-down actions, companies say the system looks useful but that it should only be used for matters that do not require discovery or the possibility for appeal. Read more..

Aerospace and medical device companies want considered injunctions in Germany 

Airbus, Huawei and a medical device company say they would like to see German judges consider the value of patents and preliminary enforceability more carefully before they issue injunctions. Read more... 

Personalised medicines face unique patenting challenges say pharma innovators 

With multiple pieces and parts, protecting CAR-T therapies is more like patenting a mobile phone than a single-molecule drug, according to counsel at Celgene and other drug innovators. Read more... 


Comments






More from the Managing IP blog


null null null

nullnullnull

null

July /August 2019

AI and IP: the view from above

Managing IP speaks to the directors of WIPO and the EUIPO to gauge their views on AI, asking how the technology can help the offices be more efficient and whether job losses are inevitable



Most read articles

Supplements